Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-05-31
2005-05-31
Lacourciere, Karen (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C536S024500, C536S024300
Reexamination Certificate
active
06900186
ABSTRACT:
The present invention relates generally to a method for the prophylaxis and/or treatment of skin disorders, and in particular proliferative and/or inflamatory skin disorders, and to genetic molecules useful for same. The present invention is particularly directed to genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes to inhibit, reduce or otherwise decrease stimulation of this layer of cells. The present invention contemplates, in a most preferred embodiment, a method for the prophylaxis and/or treatment of psoriasis.
REFERENCES:
patent: 5585479 (1996-12-01), Hoke et al.
patent: 5643788 (1997-07-01), Baserga et al.
patent: 5681940 (1997-10-01), Wang et al.
patent: 5929040 (1999-07-01), Werther et al.
patent: 6071891 (2000-06-01), Low et al.
patent: CN 1237582 (1999-12-01), None
patent: WO9422486 (1994-10-01), None
patent: WO9423034 (1994-10-01), None
patent: 9601636 (1996-01-01), None
patent: WO9610401 (1996-04-01), None
patent: WO 96/10401 (1996-04-01), None
patent: WO 98/22579 (1998-05-01), None
patent: WO 99/60855 (1999-12-01), None
Green et al, Antisense Oligonucleotides: An Evolving Technology for the Modulation of Gene Express In Human Disease, Jul. 2000, Antisense Therapy in Human Disease, vol. 191, pp. 93-105.*
Jen et al, Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies, Stem Cells 2000, vol. 18, pp. 307-319.*
Sudhir Agrawal, Antisense Oligonucleotides: Towards Clinical Trials, Oct. 1996, TIBTECH, vol 14, pp. 376-387.*
Andrea D. Branch, A Good Antisense Molecule is Hard to Find, Feb. 1998, TIBS 23, pp. 45-50.*
Batch et al. (1994) Journal of Clinical Endocrinology and Metabolism 79:1444.
Cohick et al. (1993) Growth Regulation, 20-23.
Gewirtz et al. z91996) Proc. Natl. Acad. Sci. USA 93:3161.
Gouy (1987) in “Nucleic Acid and Protein Sequence Analysis: A Practical Approach” Bishop et al., eds. IRL Press, Oxford, 259-284.
Hodak et al. (1996) Journal of Investigative Dermatology 106:564.
Gura (1995) Science 270-575.
Long et al. (1995) Cancer Research 55:1006.
Resnicoff et al. (1994) Cancer Research 54:4848.
Rojanasukul (1996) Advanced Drug Delivery Reviews 18:115.
Shapiro et al. (1994) J. Clin. Invst. 94:1235.
Singh et al. (1994) Cancer Research 54:6563.
Stein et al. (1999) Nature Biotechnology 17:209.
Stull et al. (1995) Pharmaceutical Research 12:465.
Antisense '97 : A roundtable on the state of the industry, Nature Biotechnology 15:519.
U.S. Appl. No. 09/199,926, filed Nov. 25, 1998.
Edmondson Stephanie Ruth
Werther George Arthur
Wraight Christopher John
Baker & Botts LLP
Lacourciere Karen
Murdock Children's Research Institute
LandOfFree
Method for the prophylaxis and/or treatment of medical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the prophylaxis and/or treatment of medical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prophylaxis and/or treatment of medical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3443102